Ginkgo Bioworks Holdings, Inc. (DNA) Social Stream
GINKGO BIOWORKS HOLDINGS INC (DNA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering GINKGO BIOWORKS HOLDINGS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 3 | $14.5 | $14 | $14.25 | $1.53 | 831.37% |
| 2021-11-29 | 3 | $16 | $14 | $14.833 | $1.53 | 869.48% |
| 2021-12-14 | 4 | $14.5 | $14 | $14.166 | $1.53 | 825.88% |
| 2022-01-13 | 4 | $14.5 | $12 | $13.625 | $1.53 | 790.52% |
| 2022-01-18 | 4 | $14.5 | $11.5 | $13 | $1.53 | 749.67% |
| 2022-01-28 | 5 | $14.5 | $8 | $12 | $1.53 | 684.31% |
| 2022-02-01 | 6 | $14.5 | $6 | $11.6 | $1.53 | 658.17% |
| 2022-03-31 | 6 | $14.5 | $6 | $10.666 | $1.53 | 597.12% |
| 2022-04-04 | 6 | $14 | $6 | $10.166 | $1.53 | 564.44% |
| 2022-05-18 | 7 | $14 | $3 | $9.285 | $1.53 | 506.86% |
| 2022-08-16 | 7 | $14 | $3 | $8.264 | $1.53 | 440.13% |
| 2022-09-17 | 7 | $14.5 | $3 | $9.418 | $1.53 | 515.56% |
| 2022-11-16 | 8 | $14.5 | $3 | $7.793 | $1.53 | 409.35% |
| 2022-11-21 | 8 | $14.5 | $3 | $7.231 | $1.53 | 372.61% |
| 2022-11-29 | 9 | $14.5 | $3 | $7.094 | $1.53 | 363.66% |
| 2022-12-19 | 9 | $14.5 | $3 | $6.988 | $1.53 | 356.73% |
| 2023-02-08 | 9 | $14.5 | $2 | $6.877 | $1.53 | 349.48% |
| 2023-03-03 | 8 | $14.5 | $2 | $6.862 | $1.53 | 348.5% |
| 2023-04-13 | 7 | $14.5 | $1.7 | $5.514 | $1.53 | 260.39% |
| 2023-05-17 | 7 | $14.5 | $1.7 | $5.514 | $1.53 | 260.39% |
| 2023-06-26 | 8 | $14.5 | $1.25 | $4.981 | $1.53 | 225.56% |
| 2023-08-11 | 8 | $14.5 | $1.25 | $4.956 | $1.53 | 223.92% |
| 2023-08-21 | 7 | $6 | $1.25 | $3.592 | $1.53 | 134.77% |
| 2023-10-03 | 8 | $6 | $1.25 | $3.378 | $1.53 | 120.78% |
| 2023-11-08 | 9 | $6 | $1.25 | $3.378 | $1.53 | 120.78% |
| 2023-11-13 | 9 | $7 | $1.25 | $3.831 | $1.53 | 150.39% |
| 2023-11-14 | 9 | $7 | $1.25 | $3.456 | $1.53 | 125.88% |
The Trend in the Analyst Price Target
Over the past 52 weeks, DNA's average price target has gone down $4.84.
DNA reports an average of 235.32% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-03 | 7 | 14.5 | 2.0 | 6.862 | 1.39 | 393.67% |
| 2023-03-03 | 8 | 14.5 | 1.7 | 5.942 | 1.39 | 327.48% |
| 2023-04-13 | 7 | 14.5 | 1.7 | 5.514 | 1.32 | 317.73% |
| 2023-05-11 | 7 | 14.5 | 1.7 | 5.514 | 1.33 | 314.59% |
| 2023-05-17 | 8 | 14.5 | 1.7 | 5.514 | 1.27 | 334.17% |
DNA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.67 | 3 | 0 | 4 | 1 | 1 | 9 |
The Trend in the Broker Recommendations
DNA's average broker recommendation rating worsened by 0.81 over the prior 31 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how GINKGO BIOWORKS HOLDINGS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 3954.62% of that group.
- In the context of all US stocks, GINKGO BIOWORKS HOLDINGS INC's variance in analysts' estimates is lower than -3208.74% of them.
- DNA has a greater average analyst price target than 147.79% of stocks in the large market cap category.
- GINKGO BIOWORKS HOLDINGS INC's number of analysts covering the stock is higher than 486.12% of stocks in the large market cap category.
Stocks similar to GINKGO BIOWORKS HOLDINGS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CGC, TLRY, and GLPG.
View All Top Stocks by Price Target
Make investment decisions regarding DNA using the data that counts. Try POWR Ratings for free.